New 52 Week High Today

Cardiol Therapeutics Inc CRDL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:07 AM EDT
2.28quote price arrow up+0.10 (+4.59%)
Volume
135,723
52 week range
0.55 - 2.30
Loading...
  • Open2.27
  • Day High2.30
  • Day Low2.21
  • Prev Close2.18
  • 52 Week High2.30
  • 52 Week High Date05/15/24
  • 52 Week Low0.55
  • 52 Week Low Date05/16/23

Key Stats

  • Market Cap146.57M
  • Shares Out68.28M
  • 10 Day Average Volume0.34M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change164.47

KEY STATS

  • Open2.27
  • Day High2.30
  • Day Low2.21
  • Prev Close2.18
  • 52 Week High2.30
  • 52 Week High Date05/15/24
  • 52 Week Low0.55
  • 52 Week Low Date05/16/23
  • Market Cap146.57M
  • Shares Out68.28M
  • 10 Day Average Volume0.34M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change164.47

RATIOS/PROFITABILITY

  • EPS (TTM)-0.33
  • P/E (TTM)-6.92
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cardiol Therapeutics Inc

 

Profile

MORE
Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an...
Guillermo Torre-Amione M.D., Ph.D
Independent Chairman of the Board
David Elsley
President, Chief Executive Officer, Director
Bernard Lim
Chief Operating Officer
Christopher Waddick CPA
Chief Financial Officer, Corporate Secretary, Director
Address
602-2265 Upper Middle Road East
Oakville, ON
L6H 0G5
Canada